Donald A Barkauskas

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 25

Top Topics

Acute Lymphoblastic Leukemia

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Pediatric blood & cancer

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Birte Wistinghausen, Keri Toner, Donald A Barkauskas, Lauren P Jerkins, Hannah Kinoshita, Pamela A Chansky, Gloria Pezzella, Lauren Saguilig, Robert J Hayashi, Harshal A Abhyankar, Brooks Scull, Vivekanudeep Karri, Jay Tanna, Patrick J Hanley, Michelle L Hermiston, Carl E Allen, Catherine M Bollard
ANHL1522: Durable Immunity to EBV post Rituximab and Third Party LMP-specific T-cells: A Children's Oncology Group Study. Blood advances (2024)
Birte Wistinghausen, Keri Toner, Donald A Barkauskas, Lauren P Jerkins, Hannah Kinoshita, Pamela A Chansky, Gloria Pezzella, Lauren Saguilig, Robert J Hayashi, Harshal A Abhyankar, Brooks Scull, Vivekanudeep Karri, Jay Tanna, Patrick J Hanley, Michelle L Hermiston, Carl E Allen, Catherine M Bollard
ANHL1522: Durable Immunity to EBV post Rituximab and Third Party LMP-specific T-cells: A Children's Oncology Group Study. Blood advances (2024)
Elliot Stieglitz, Alex G Lee, Steven P Angus, Christopher Davis, Donald A Barkauskas, David C Hall, Scott C Kogan, Julia Meyer, Steven D Rhodes, Sarah K Tasian, Xiaoling Xuei, Kevin Shannon, Mignon L Loh, Elizabeth Fox, Brenda J Weigel
Efficacy of the Allosteric MEK Inhibitor Trametinib in Relapsed and Refractory Juvenile Myelomonocytic Leukemia: a Report from the Children's Oncology Group. Cancer discovery (2024)
David P Douglass, Cheryl M Coffin, R Lor Randall, Yan Yang, Donald A Barkauskas, Lynn Million, Elizabeth B McCarville, Alberto S Pappo, Aaron R Weiss, Sheri L Spunt
Clinical features and outcomes of young patients with low-grade non-rhabdomyosarcoma soft tissue sarcomas treated with a risk-based strategy: A report from Children's Oncology Group study ARST0332. Pediatric blood & cancer 71 (8) (2024)
Birte Wistinghausen, Keri Toner, Donald A Barkauskas, Lauren P Jerkins, Hannah Kinoshita, Pamela A Chansky, Gloria Pezzella, Lauren Saguilig, Robert J Hayashi, Harshal Abhyankar, Brooks Scull, Vivekanudeep Karri, Jay Tanna, Patrick Hanley, Michelle L Hermiston, Carl E Allen, Catherine M Bollard
Durable immunity to EBV after rituximab and third-party LMP-specific T cells: a Children's Oncology Group study. Blood advances 8 (5) (2024)
David P Douglass, Cheryl M Coffin, R Lor Randall, Yan Yang, Donald A Barkauskas, Lynn Million, Elizabeth B McCarville, Alberto S Pappo, Aaron R Weiss, Sheri L Spunt
Clinical features and outcomes of young patients with low-grade non-rhabdomyosarcoma soft tissue sarcomas treated with a risk-based strategy: A report from Children's Oncology Group study ARST0332. Pediatric blood & cancer 71 (8) (2024)
Birte Wistinghausen, Keri Toner, Donald A Barkauskas, Lauren P Jerkins, Hannah Kinoshita, Pamela A Chansky, Gloria Pezzella, Lauren Saguilig, Robert J Hayashi, Harshal Abhyankar, Brooks Scull, Vivekanudeep Karri, Jay Tanna, Patrick Hanley, Michelle L Hermiston, Carl E Allen, Catherine M Bollard
Durable immunity to EBV after rituximab and third-party LMP-specific T cells: a Children's Oncology Group study. Blood advances 8 (5) (2024)
Elliot Stieglitz, Alex G Lee, Steven P Angus, Christopher Davis, Donald A Barkauskas, David C Hall, Scott C Kogan, Julia Meyer, Steven D Rhodes, Sarah K Tasian, Xiaoling Xuei, Kevin Shannon, Mignon L Loh, Elizabeth Fox, Brenda J Weigel
Efficacy of the Allosteric MEK Inhibitor Trametinib in Relapsed and Refractory Juvenile Myelomonocytic Leukemia: a Report from the Children's Oncology Group. Cancer discovery (2024)
Birte Wistinghausen, Keri Toner, Donald A Barkauskas, Lauren P Jerkins, Hannah Kinoshita, Pamela A Chansky, Gloria Pezzella, Lauren Saguilig, Robert J Hayashi, Harshal Abhyankar, Brooks Scull, Vivekanudeep Karri, Jay Tanna, Patrick Hanley, Michelle L Hermiston, Carl E Allen, Catherine M Bollard
Durable immunity to EBV after rituximab and third-party LMP-specific T cells: a Children's Oncology Group study. Blood advances 8 (5) (2024)
David P Douglass, Cheryl M Coffin, R Lor Randall, Yan Yang, Donald A Barkauskas, Lynn Million, Elizabeth B McCarville, Alberto S Pappo, Aaron R Weiss, Sheri L Spunt
Clinical features and outcomes of young patients with low-grade non-rhabdomyosarcoma soft tissue sarcomas treated with a risk-based strategy: A report from Children's Oncology Group study ARST0332. Pediatric blood & cancer (2024)
David P Douglass, Cheryl M Coffin, R Lor Randall, Yan Yang, Donald A Barkauskas, Lynn Million, Elizabeth B McCarville, Alberto S Pappo, Aaron R Weiss, Sheri L Spunt
Clinical features and outcomes of young patients with low-grade non-rhabdomyosarcoma soft tissue sarcomas treated with a risk-based strategy: A report from Children's Oncology Group study ARST0332. Pediatric blood & cancer (2024)
David P Douglass, Cheryl M Coffin, R Lor Randall, Yan Yang, Donald A Barkauskas, Lynn Million, Elizabeth B McCarville, Alberto S Pappo, Aaron R Weiss, Sheri L Spunt
Clinical features and outcomes of young patients with low-grade non-rhabdomyosarcoma soft tissue sarcomas treated with a risk-based strategy: A report from Children's Oncology Group study ARST0332. Pediatric blood & cancer (2024)
Elliot Stieglitz, Alex G Lee, Steven P Angus, Christopher Davis, Donald A Barkauskas, David C Hall, Scott C Kogan, Julia Meyer, Steven D Rhodes, Sarah K Tasian, Xiaoling Xuei, Kevin Shannon, Mignon L Loh, Elizabeth Fox, Brenda J Weigel
Efficacy of the Allosteric MEK Inhibitor Trametinib in Relapsed and Refractory Juvenile Myelomonocytic Leukemia: a Report from the Children's Oncology Group. Cancer discovery (2024)
Samuel Abbou, Kelly S Klega, Junko Tsuji, Mohammad Tanhaemami, David C Hall, Donald A Barkauskas, Mark D Krailo, Carrie Cibulskis, Anwesha Nag, Aaron R Thorner, Samuel Pollock, Alma Imamovic, Jack F Shern, Steven G DuBois, Rajkumar Venkatramani, Douglas S Hawkins, Brian D Crompton
Circulating Tumor DNA Is Prognostic in Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Samuel Abbou, Kelly S Klega, Junko Tsuji, Mohammad Tanhaemami, David C Hall, Donald A Barkauskas, Mark D Krailo, Carrie Cibulskis, Anwesha Nag, Aaron R Thorner, Samuel Pollock, Alma Imamovic, Jack F Shern, Steven G DuBois, Rajkumar Venkatramani, Douglas S Hawkins, Brian D Crompton
Circulating Tumor DNA Is Prognostic in Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Donghan M Yang, Qinbo Zhou, Lauren Furman-Cline, Xian Cheng, Danni Luo, Hongyin Lai, Yueqi Li, Kevin W Jin, Bo Yao, Patrick J Leavey, Dinesh Rakheja, Tammy Lo, David C Hall, Donald A Barkauskas, David S Shulman, Katherine A Janeway, Chand Khanna, Richard G Gorlick, Christopher Menzies, Xiaowei Zhan, Guanghua Xiao, Stephen X Skapek, Lin Xu, Laura J Klesse, Brian D Crompton, Yang Xie
Osteosarcoma Explorer: A Data Commons With Clinical, Genomic, Protein, and Tissue Imaging Data for Osteosarcoma Research. JCO clinical cancer informatics 7 (2023)
David Milewski, Hyun Jung, G Thomas Brown, Yanling Liu, Ben Somerville, Curtis Lisle, Marc Ladanyi, Erin R Rudzinski, Hyoyoung Choo-Wosoba, Donald A Barkauskas, Tammy Lo, David C Hall, Corinne M Linardic, Jun S Wei, Hsien-Chao Chou, Stephen X Skapek, Rajkumar Venkatramani, Peter Karl Bode, Seth M Steinberg, George Zaki, Igor B Kuznetsov, Douglas S Hawkins, Jack F Shern, Jack Collins, Javed Khan
Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients using Deep Learning of H&E Images: A Report from the Children's Oncology Group. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Eric J Lowe, Anne F Reilly, Megan S Lim, Thomas G Gross, Lauren Saguilig, Donald A Barkauskas, Rui Wu, Sarah Alexander, Catherine M Bollard
Crizotinib in Combination With Chemotherapy for Pediatric Patients With ALK+ Anaplastic Large-Cell Lymphoma: The Results of Children's Oncology Group Trial ANHL12P1. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
He Li, Saumya Dushyant Sisoudiya, Bailey A Martin-Giacalone, Michael M Khayat, Shannon Dugan, Deborah A Marquez-Do, Michael E Scheurer, Donna Muzny, Eric Boerwinkle, Richard A Gibbs, Yueh-Yun Chi, Donald A Barkauskas, Tammy Lo, David C Hall, Douglas R Stewart, Joshua D Schiffman, Stephen X Skapek, Douglas S Hawkins, Sharon E Plon, Aniko Sabo, Philip J Lupo
Germline Cancer Predisposition Variants in Pediatric Rhabdomyosarcoma: A Report From the Children's Oncology Group. Journal of the National Cancer Institute 113 (7) (2022)
Gladstone A A Burke, Veronique Minard Colin, Anne Aupérin, Sarah Alexander, Marta Pillon, Rafael Delgado, József Zsíros, Anne Uyttebroeck, Peggy Dartigues, Rodney R Miles, Bernarda Kazanowska, Alan Kwok Shing Chiang, Stéphanie Haouy, Catherine M Bollard, Monika Csoka, Keith Wheatley, Donald A Barkauskas, Peter C Adamson, Gilles Vassal, Catherine Patte, Thomas G Gross
Reply to R. Lakhotia et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (18) (2022)
Eric J Lowe, Anne F Reilly, Megan S Lim, Thomas G Gross, Lauren Saguilig, Donald A Barkauskas, Rui Wu, Sarah Alexander, Catherine M Bollard
Crizotinib in Combination With Chemotherapy for Pediatric Patients With ALK+ Anaplastic Large-Cell Lymphoma: The Results of Children's Oncology Group Trial ANHL12P1. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Gladstone A A Burke, Veronique Minard Colin, Anne Aupérin, Sarah Alexander, Marta Pillon, Rafael Delgado, József Zsíros, Anne Uyttebroeck, Peggy Dartigues, Rodney R Miles, Bernarda Kazanowska, Alan Kwok Shing Chiang, Stéphanie Haouy, Catherine M Bollard, Monika Csoka, Keith Wheatley, Donald A Barkauskas, Peter C Adamson, Gilles Vassal, Catherine Patte, Thomas G Gross
Dose-Adjusted Etoposide, Doxorubicin, and Cyclophosphamide With Vincristine and Prednisone Plus Rituximab Therapy in Children and Adolescents With Primary Mediastinal B-Cell Lymphoma: A Multicenter Phase II Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (33) (2021)
Eric J Lowe, Anne F Reilly, Megan S Lim, Thomas G Gross, Lauren Saguilig, Donald A Barkauskas, Rui Wu, Sarah Alexander, Catherine M Bollard
Brentuximab vedotin in combination with chemotherapy for pediatric patients with ALK+ ALCL: results of COG trial ANHL12P1. Blood 137 (26) (2021)
Jack F Shern, Joanna L Selfe, Elisa Izquierdo, Rajesh Patidar, Hsien-Chao Chou, Young K Song, Marielle E Yohe, Sivasish Sindiri, Jun S Wei, Xinyu Wen, Erin R Rudzinski, Donald A Barkauskas, Tammy Lo, David C Hall, Corinne M Linardic, Debbie Hughes, Sabri Jamal, Meriel Jenney, Julia C Chisholm, Rebecca Brown, Kristine Jones, Belynda D Hicks, Paola Angelini, Sally L George, Louis Chesler, Michael Hubank, Anna Kelsey, Susanne Andrea Gatz, Stephen X Skapek, Douglas S Hawkins, Janet M Shipley, Javed Khan
Genomic Classification and Clinical Outcome in Rhabdomyosarcoma: A Report From an International Consortium. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (26) (2021)
Mina Nikanjam, Jose Tinajero, Donald A Barkauskas, Razelle Kurzrock
BRAF V600E/V600K Mutations versus Nonstandard Alterations: Prognostic Implications and Therapeutic Outcomes. Molecular cancer therapeutics 20 (6) (2021)